APO Research
Talk to an analyst

APO RESEARCH · REPORT

HMO Infant Formula

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global HMO Infant Formula Market Analysis and Forecast 2026-2032

6 January 2026198 pages

Choose your research edition.

Industry ResearchHMO Infant Formula Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal HMO Infant Formula Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal HMO Infant Formula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HMO Infant Formula Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal HMO Infant Formula Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global HMO Infant Formula market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for HMO Infant Formula is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for HMO Infant Formula is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for HMO Infant Formula is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for HMO Infant Formula is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of HMO Infant Formula include Abbott, Mead Johnson（Reckitt）, Nestlé（Wyeth Nutrition）, Danone (Aptamil), FrieslandCampina (Friso), Biostime and Yili Group (Ausnutria Dairy), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for HMO Infant Formula, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of HMO Infant Formula, also provides the sales of main regions and countries. Of the upcoming market potential for HMO Infant Formula, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the HMO Infant Formula sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global HMO Infant Formula market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for HMO Infant Formula sales, projected growth trends, production technology, application and end-user industry.

HMO Infant Formula Segment by Company

Abbott

Mead Johnson（Reckitt）

Nestlé（Wyeth Nutrition）

Danone (Aptamil)

FrieslandCampina (Friso)

Biostime

Yili Group (Ausnutria Dairy)

HMO Infant Formula Segment by Type

2'-Fucosyllactose (2'-FL)

Others

HMO Infant Formula Segment by Application

Online Channel

Specialty Store

Supermarket

Others

HMO Infant Formula Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HMO Infant Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HMO Infant Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HMO Infant Formula.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of HMO Infant Formula in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of HMO Infant Formula manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HMO Infant Formula sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HMO Infant Formula Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 2'-Fucosyllactose (2'-FL) Major Manufacturers Table 3. Others Major Manufacturers Table 4. Global HMO Infant Formula Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Online Channel Major Manufacturers Table 6. Specialty Store Major Manufacturers Table 7. Supermarket Major Manufacturers Table 8. Others Major Manufacturers Table 9. HMO Infant Formula Industry Trends Table 10. HMO Infant Formula Industry Drivers Table 11. HMO Infant Formula Industry Opportunities and Challenges Table 12. HMO Infant Formula Industry Restraints Table 13. Global HMO Infant Formula Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global HMO Infant Formula Revenue by Region (2021-2026) & (US$ Million) Table 15. Global HMO Infant Formula Revenue by Region (2027-2032) & (US$ Million) Table 16. Global HMO Infant Formula Revenue Market Share by Region (2021-2026) Table 17. Global HMO Infant Formula Revenue Market Share by Region (2027-2032) Table 18. Global HMO Infant Formula Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 19. Global HMO Infant Formula Sales by Region (2021-2026) & (t) Table 20. Global HMO Infant Formula Sales by Region (2027-2032) & (t) Table 21. Global HMO Infant Formula Sales Market Share by Region (2021-2026) Table 22. Global HMO Infant Formula Sales Market Share by Region (2027-2032) Table 23. Global HMO Infant Formula Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global HMO Infant Formula Revenue Market Share by Manufacturers (2021-2026) Table 25. Global HMO Infant Formula Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global HMO Infant Formula Sales Market Share by Manufacturers (2021-2026) Table 27. Global HMO Infant Formula Sales Price (USD/kg) of Manufacturers (2021-2026) Table 28. Global HMO Infant Formula Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global HMO Infant Formula Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global HMO Infant Formula Manufacturers, Product Type & Application Table 31. Global HMO Infant Formula Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global HMO Infant Formula by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global HMO Infant Formula Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global HMO Infant Formula Revenue by Type (2021-2026) & (US$ Million) Table 36. Global HMO Infant Formula Revenue by Type (2027-2032) & (US$ Million) Table 37. Global HMO Infant Formula Revenue Market Share by Type (2021-2026) Table 38. Global HMO Infant Formula Revenue Market Share by Type (2027-2032) Table 39. Global HMO Infant Formula Sales by Type 2021 VS 2025 VS 2032 (t) Table 40. Global HMO Infant Formula Sales by Type (2021-2026) & (t) Table 41. Global HMO Infant Formula Sales by Type (2027-2032) & (t) Table 42. Global HMO Infant Formula Sales Market Share by Type (2021-2026) Table 43. Global HMO Infant Formula Sales Market Share by Type (2027-2032) Table 44. Global HMO Infant Formula Price by Type (2021-2026) & (USD/kg) Table 45. Global HMO Infant Formula Price by Type (2027-2032) & (USD/kg) Table 46. Global HMO Infant Formula Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global HMO Infant Formula Revenue by Application (2021-2026) & (US$ Million) Table 48. Global HMO Infant Formula Revenue by Application (2027-2032) & (US$ Million) Table 49. Global HMO Infant Formula Revenue Market Share by Application (2021-2026) Table 50. Global HMO Infant Formula Revenue Market Share by Application (2027-2032) Table 51. Global HMO Infant Formula Sales by Application 2021 VS 2025 VS 2032 (t) Table 52. Global HMO Infant Formula Sales by Application (2021-2026) & (t) Table 53. Global HMO Infant Formula Sales by Application (2027-2032) & (t) Table 54. Global HMO Infant Formula Sales Market Share by Application (2021-2026) Table 55. Global HMO Infant Formula Sales Market Share by Application (2027-2032) Table 56. Global HMO Infant Formula Price by Application (2021-2026) & (USD/kg) Table 57. Global HMO Infant Formula Price by Application (2027-2032) & (USD/kg) Table 58. Abbott Company Information Table 59. Abbott Business Overview Table 60. Abbott HMO Infant Formula Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 61. Abbott HMO Infant Formula Product Portfolio Table 62. Abbott Recent Development Table 63. Mead Johnson（Reckitt） Company Information Table 64. Mead Johnson（Reckitt） Business Overview Table 65. Mead Johnson（Reckitt） HMO Infant Formula Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 66. Mead Johnson（Reckitt） HMO Infant Formula Product Portfolio Table 67. Mead Johnson（Reckitt） Recent Development Table 68. Nestlé（Wyeth Nutrition） Company Information Table 69. Nestlé（Wyeth Nutrition） Business Overview Table 70. Nestlé（Wyeth Nutrition） HMO Infant Formula Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 71. Nestlé（Wyeth Nutrition） HMO Infant Formula Product Portfolio Table 72. Nestlé（Wyeth Nutrition） Recent Development Table 73. Danone (Aptamil) Company Information Table 74. Danone (Aptamil) Business Overview Table 75. Danone (Aptamil) HMO Infant Formula Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 76. Danone (Aptamil) HMO Infant Formula Product Portfolio Table 77. Danone (Aptamil) Recent Development Table 78. FrieslandCampina (Friso) Company Information Table 79. FrieslandCampina (Friso) Business Overview Table 80. FrieslandCampina (Friso) HMO Infant Formula Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 81. FrieslandCampina (Friso) HMO Infant Formula Product Portfolio Table 82. FrieslandCampina (Friso) Recent Development Table 83. Biostime Company Information Table 84. Biostime Business Overview Table 85. Biostime HMO Infant Formula Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 86. Biostime HMO Infant Formula Product Portfolio Table 87. Biostime Recent Development Table 88. Yili Group (Ausnutria Dairy) Company Information Table 89. Yili Group (Ausnutria Dairy) Business Overview Table 90. Yili Group (Ausnutria Dairy) HMO Infant Formula Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 91. Yili Group (Ausnutria Dairy) HMO Infant Formula Product Portfolio Table 92. Yili Group (Ausnutria Dairy) Recent Development Table 93. North America HMO Infant Formula Revenue by Type (2021-2026) & (US$ Million) Table 94. North America HMO Infant Formula Revenue by Type (2027-2032) & (US$ Million) Table 95. North America HMO Infant Formula Sales by Type (2021-2026) & (t) Table 96. North America HMO Infant Formula Sales by Type (2027-2032) & (t) Table 97. North America HMO Infant Formula Sales Price by Type (2021-2026) & (USD/kg) Table 98. North America HMO Infant Formula Sales Price by Type (2027-2032) & (USD/kg) Table 99. North America HMO Infant Formula Revenue by Application (2021-2026) & (US$ Million) Table 100. North America HMO Infant Formula Revenue by Application (2027-2032) & (US$ Million) Table 101. North America HMO Infant Formula Sales by Application (2021-2026) & (t) Table 102. North America HMO Infant Formula Sales by Application (2027-2032) & (t) Table 103. North America HMO Infant Formula Sales Price by Application (2021-2026) & (USD/kg) Table 104. North America HMO Infant Formula Sales Price by Application (2027-2032) & (USD/kg) Table 105. North America HMO Infant Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America HMO Infant Formula Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America HMO Infant Formula Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America HMO Infant Formula Sales by Country (2021 VS 2025 VS 2032) & (t) Table 109. North America HMO Infant Formula Sales by Country (2021-2026) & (t) Table 110. North America HMO Infant Formula Sales by Country (2027-2032) & (t) Table 111. North America HMO Infant Formula Sales Price by Country (2021-2026) & (USD/kg) Table 112. North America HMO Infant Formula Sales Price by Country (2027-2032) & (USD/kg) Table 113. United States HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 114. Canada HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 115. Mexico HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 116. Europe HMO Infant Formula Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe HMO Infant Formula Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe HMO Infant Formula Sales by Type (2021-2026) & (t) Table 119. Europe HMO Infant Formula Sales by Type (2027-2032) & (t) Table 120. Europe HMO Infant Formula Sales Price by Type (2021-2026) & (USD/kg) Table 121. Europe HMO Infant Formula Sales Price by Type (2027-2032) & (USD/kg) Table 122. Europe HMO Infant Formula Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe HMO Infant Formula Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe HMO Infant Formula Sales by Application (2021-2026) & (t) Table 125. Europe HMO Infant Formula Sales by Application (2027-2032) & (t) Table 126. Europe HMO Infant Formula Sales Price by Application (2021-2026) & (USD/kg) Table 127. Europe HMO Infant Formula Sales Price by Application (2027-2032) & (USD/kg) Table 128. Europe HMO Infant Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe HMO Infant Formula Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe HMO Infant Formula Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe HMO Infant Formula Sales by Country (2021 VS 2025 VS 2032) & (t) Table 132. Europe HMO Infant Formula Sales by Country (2021-2026) & (t) Table 133. Europe HMO Infant Formula Sales by Country (2027-2032) & (t) Table 134. Europe HMO Infant Formula Sales Price by Country (2021-2026) & (USD/kg) Table 135. Europe HMO Infant Formula Sales Price by Country (2027-2032) & (USD/kg) Table 136. Germany HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 137. France HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 138. U.K. HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 139. Italy HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 140. Russia HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 141. Spain HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 142. Netherlands HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 143. Switzerland HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 144. Sweden HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 145. Poland HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 146. China HMO Infant Formula Revenue by Type (2021-2026) & (US$ Million) Table 147. China HMO Infant Formula Revenue by Type (2027-2032) & (US$ Million) Table 148. China HMO Infant Formula Sales by Type (2021-2026) & (t) Table 149. China HMO Infant Formula Sales by Type (2027-2032) & (t) Table 150. China HMO Infant Formula Sales Price by Type (2021-2026) & (USD/kg) Table 151. China HMO Infant Formula Sales Price by Type (2027-2032) & (USD/kg) Table 152. China HMO Infant Formula Revenue by Application (2021-2026) & (US$ Million) Table 153. China HMO Infant Formula Revenue by Application (2027-2032) & (US$ Million) Table 154. China HMO Infant Formula Sales by Application (2021-2026) & (t) Table 155. China HMO Infant Formula Sales by Application (2027-2032) & (t) Table 156. China HMO Infant Formula Sales Price by Application (2021-2026) & (USD/kg) Table 157. China HMO Infant Formula Sales Price by Application (2027-2032) & (USD/kg) Table 158. Asia HMO Infant Formula Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia HMO Infant Formula Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia HMO Infant Formula Sales by Type (2021-2026) & (t) Table 161. Asia HMO Infant Formula Sales by Type (2027-2032) & (t) Table 162. Asia HMO Infant Formula Sales Price by Type (2021-2026) & (USD/kg) Table 163. Asia HMO Infant Formula Sales Price by Type (2027-2032) & (USD/kg) Table 164. Asia HMO Infant Formula Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia HMO Infant Formula Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia HMO Infant Formula Sales by Application (2021-2026) & (t) Table 167. Asia HMO Infant Formula Sales by Application (2027-2032) & (t) Table 168. Asia HMO Infant Formula Sales Price by Application (2021-2026) & (USD/kg) Table 169. Asia HMO Infant Formula Sales Price by Application (2027-2032) & (USD/kg) Table 170. Asia HMO Infant Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia HMO Infant Formula Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia HMO Infant Formula Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia HMO Infant Formula Sales by Country (2021 VS 2025 VS 2032) & (t) Table 174. Asia HMO Infant Formula Sales by Country (2021-2026) & (t) Table 175. Asia HMO Infant Formula Sales by Country (2027-2032) & (t) Table 176. Asia HMO Infant Formula Sales Price by Country (2021-2026) & (USD/kg) Table 177. Asia HMO Infant Formula Sales Price by Country (2027-2032) & (USD/kg) Table 178. Japan HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 179. South Korea HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 180. India HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 181. Australia HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 182. Taiwan HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 184. SAMEA HMO Infant Formula Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA HMO Infant Formula Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA HMO Infant Formula Sales by Type (2021-2026) & (t) Table 187. SAMEA HMO Infant Formula Sales by Type (2027-2032) & (t) Table 188. SAMEA HMO Infant Formula Sales Price by Type (2021-2026) & (USD/kg) Table 189. SAMEA HMO Infant Formula Sales Price by Type (2027-2032) & (USD/kg) Table 190. SAMEA HMO Infant Formula Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA HMO Infant Formula Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA HMO Infant Formula Sales by Application (2021-2026) & (t) Table 193. SAMEA HMO Infant Formula Sales by Application (2027-2032) & (t) Table 194. SAMEA HMO Infant Formula Sales Price by Application (2021-2026) & (USD/kg) Table 195. SAMEA HMO Infant Formula Sales Price by Application (2027-2032) & (USD/kg) Table 196. SAMEA HMO Infant Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA HMO Infant Formula Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA HMO Infant Formula Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA HMO Infant Formula Sales by Country (2021 VS 2025 VS 2032) & (t) Table 200. SAMEA HMO Infant Formula Sales by Country (2021-2026) & (t) Table 201. SAMEA HMO Infant Formula Sales by Country (2027-2032) & (t) Table 202. SAMEA HMO Infant Formula Sales Price by Country (2021-2026) & (USD/kg) Table 203. SAMEA HMO Infant Formula Sales Price by Country (2027-2032) & (USD/kg) Table 204. Brazil HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 205. Argentina HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 206. Chile HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 207. Colombia HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 208. Peru HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 210. Israel HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 211. UAE HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 212. Turkey HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 213. Iran HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 214. Egypt HMO Infant Formula Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. HMO Infant Formula Distributors List Table 218. HMO Infant Formula Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. HMO Infant Formula Image Figure 2. Global HMO Infant Formula Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HMO Infant Formula Market Size Share 2021 VS 2025 VS 2032 Figure 4. 2'-Fucosyllactose (2'-FL) Image Figure 5. Others Image Figure 6. Global HMO Infant Formula Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global HMO Infant Formula Market Size Share 2021 VS 2025 VS 2032 Figure 8. Online Channel Image Figure 9. Specialty Store Image Figure 10. Supermarket Image Figure 11. Others Image Figure 12. Global HMO Infant Formula Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global HMO Infant Formula Revenue (2021-2032) & (US$ Million) Figure 14. Global HMO Infant Formula Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global HMO Infant Formula Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global HMO Infant Formula Revenue Market Share by Region (2021-2032) Figure 17. Global HMO Infant Formula Sales (2021-2032) & (t) Figure 18. Global HMO Infant Formula Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 19. Global HMO Infant Formula Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico HMO Infant Formula Sales YoY (2021-2032) & (t) Figure 21. Europe HMO Infant Formula Sales YoY (2021-2032) & (t) Figure 22. China HMO Infant Formula Sales YoY (2021-2032) & (t) Figure 23. Asia (Excluding China) HMO Infant Formula Sales YoY (2021-2032) & (t) Figure 24. South America, Middle East and Africa HMO Infant Formula Sales YoY (2021-2032) & (t) Figure 25. Global HMO Infant Formula Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global HMO Infant Formula Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global HMO Infant Formula Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global HMO Infant Formula Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global HMO Infant Formula Revenue Market Share by Type (2021-2032) Figure 31. Global HMO Infant Formula Sales by Type (2021 VS 2025 VS 2032) & (t) Figure 32. Global HMO Infant Formula Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global HMO Infant Formula Sales Market Share by Type (2021-2032) Figure 34. Global HMO Infant Formula Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global HMO Infant Formula Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global HMO Infant Formula Revenue Market Share by Application (2021-2032) Figure 37. Global HMO Infant Formula Sales by Application (2021 VS 2025 VS 2032) & (t) Figure 38. Global HMO Infant Formula Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global HMO Infant Formula Sales Market Share by Application (2021-2032) Figure 40. North America HMO Infant Formula Revenue Share by Type (2021-2032) Figure 41. North America HMO Infant Formula Sales Share by Type (2021-2032) Figure 42. North America HMO Infant Formula Revenue Share by Application (2021-2032) Figure 43. North America HMO Infant Formula Sales Share by Application (2021-2032) Figure 44. North America HMO Infant Formula Revenue Share by Country (2021-2032) Figure 45. North America HMO Infant Formula Sales Share by Country (2021-2032) Figure 46. Europe HMO Infant Formula Revenue Share by Type (2021-2032) Figure 47. Europe HMO Infant Formula Sales Share by Type (2021-2032) Figure 48. Europe HMO Infant Formula Revenue Share by Application (2021-2032) Figure 49. Europe HMO Infant Formula Sales Share by Application (2021-2032) Figure 50. Europe HMO Infant Formula Revenue Share by Country (2021-2032) Figure 51. Europe HMO Infant Formula Sales Share by Country (2021-2032) Figure 52. China HMO Infant Formula Revenue Share by Type (2021-2032) Figure 53. China HMO Infant Formula Sales Share by Type (2021-2032) Figure 54. China HMO Infant Formula Revenue Share by Application (2021-2032) Figure 55. China HMO Infant Formula Sales Share by Application (2021-2032) Figure 56. Asia HMO Infant Formula Revenue Share by Type (2021-2032) Figure 57. Asia HMO Infant Formula Sales Share by Type (2021-2032) Figure 58. Asia HMO Infant Formula Revenue Share by Application (2021-2032) Figure 59. Asia HMO Infant Formula Sales Share by Application (2021-2032) Figure 60. Asia HMO Infant Formula Revenue Share by Country (2021-2032) Figure 61. Asia HMO Infant Formula Sales Share by Country (2021-2032) Figure 62. SAMEA HMO Infant Formula Revenue Share by Type (2021-2032) Figure 63. SAMEA HMO Infant Formula Sales Share by Type (2021-2032) Figure 64. SAMEA HMO Infant Formula Revenue Share by Application (2021-2032) Figure 65. SAMEA HMO Infant Formula Sales Share by Application (2021-2032) Figure 66. SAMEA HMO Infant Formula Revenue Share by Country (2021-2032) Figure 67. SAMEA HMO Infant Formula Sales Share by Country (2021-2032) Figure 68. HMO Infant Formula Value Chain Figure 69. Manufacturing Cost Structure Figure 70. HMO Infant Formula Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 2'-Fucosyllactose (2'-FL)
  • Others
Applications
  • Online Channel
  • Specialty Store
  • Supermarket
  • Others
Companies covered
  • Abbott
  • Mead Johnson（Reckitt）
  • Nestlé（Wyeth Nutrition）
  • Danone (Aptamil)
  • FrieslandCampina (Friso)
  • Biostime
  • Yili Group (Ausnutria Dairy)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 HMO Infant Formula Market by Type
  3. 1.2.1 Global HMO Infant Formula Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 2'-Fucosyllactose (2'-FL)
  5. 1.2.3 Others
  6. 1.3 HMO Infant Formula Market by Application
  7. 1.3.1 Global HMO Infant Formula Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Online Channel
  9. 1.3.3 Specialty Store
  10. 1.3.4 Supermarket
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 HMO Infant Formula Market Dynamics
  1. 2.1 HMO Infant Formula Industry Trends
  2. 2.2 HMO Infant Formula Industry Drivers
  3. 2.3 HMO Infant Formula Industry Opportunities and Challenges
  4. 2.4 HMO Infant Formula Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global HMO Infant Formula Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global HMO Infant Formula Revenue by Region
  3. 3.2.1 Global HMO Infant Formula Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global HMO Infant Formula Revenue by Region (2021-2026)
  5. 3.2.3 Global HMO Infant Formula Revenue by Region (2027-2032)
  6. 3.2.4 Global HMO Infant Formula Revenue Market Share by Region (2021-2032)
  7. 3.3 Global HMO Infant Formula Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global HMO Infant Formula Sales by Region
  9. 3.4.1 Global HMO Infant Formula Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global HMO Infant Formula Sales by Region (2021-2026)
  11. 3.4.3 Global HMO Infant Formula Sales by Region (2027-2032)
  12. 3.4.4 Global HMO Infant Formula Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global HMO Infant Formula Revenue by Manufacturers
  2. 4.1.1 Global HMO Infant Formula Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global HMO Infant Formula Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global HMO Infant Formula Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global HMO Infant Formula Sales by Manufacturers
  6. 4.2.1 Global HMO Infant Formula Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global HMO Infant Formula Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global HMO Infant Formula Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global HMO Infant Formula Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global HMO Infant Formula Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global HMO Infant Formula Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global HMO Infant Formula Manufacturers, Product Type & Application
  13. 4.7 Global HMO Infant Formula Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global HMO Infant Formula Market CR5 and HHI
  16. 4.8.2 2025 HMO Infant Formula Tier 1, Tier 2, and Tier 3
5 HMO Infant Formula Market by Type
  1. 5.1 Global HMO Infant Formula Revenue by Type
  2. 5.1.1 Global HMO Infant Formula Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global HMO Infant Formula Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global HMO Infant Formula Revenue Market Share by Type (2021-2032)
  5. 5.2 Global HMO Infant Formula Sales by Type
  6. 5.2.1 Global HMO Infant Formula Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global HMO Infant Formula Sales by Type (2021-2032) & (t)
  8. 5.2.3 Global HMO Infant Formula Sales Market Share by Type (2021-2032)
  9. 5.3 Global HMO Infant Formula Price by Type
6 HMO Infant Formula Market by Application
  1. 6.1 Global HMO Infant Formula Revenue by Application
  2. 6.1.1 Global HMO Infant Formula Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global HMO Infant Formula Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global HMO Infant Formula Revenue Market Share by Application (2021-2032)
  5. 6.2 Global HMO Infant Formula Sales by Application
  6. 6.2.1 Global HMO Infant Formula Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global HMO Infant Formula Sales by Application (2021-2032) & (t)
  8. 6.2.3 Global HMO Infant Formula Sales Market Share by Application (2021-2032)
  9. 6.3 Global HMO Infant Formula Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott HMO Infant Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott HMO Infant Formula Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Mead Johnson（Reckitt）
  8. 7.2.1 Mead Johnson（Reckitt） Company Information
  9. 7.2.2 Mead Johnson（Reckitt） Business Overview
  10. 7.2.3 Mead Johnson（Reckitt） HMO Infant Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mead Johnson（Reckitt） HMO Infant Formula Product Portfolio
  12. 7.2.5 Mead Johnson（Reckitt） Recent Developments
  13. 7.3 Nestlé（Wyeth Nutrition）
  14. 7.3.1 Nestlé（Wyeth Nutrition） Company Information
  15. 7.3.2 Nestlé（Wyeth Nutrition） Business Overview
  16. 7.3.3 Nestlé（Wyeth Nutrition） HMO Infant Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Nestlé（Wyeth Nutrition） HMO Infant Formula Product Portfolio
  18. 7.3.5 Nestlé（Wyeth Nutrition） Recent Developments
  19. 7.4 Danone (Aptamil)
  20. 7.4.1 Danone (Aptamil) Company Information
  21. 7.4.2 Danone (Aptamil) Business Overview
  22. 7.4.3 Danone (Aptamil) HMO Infant Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Danone (Aptamil) HMO Infant Formula Product Portfolio
  24. 7.4.5 Danone (Aptamil) Recent Developments
  25. 7.5 FrieslandCampina (Friso)
  26. 7.5.1 FrieslandCampina (Friso) Company Information
  27. 7.5.2 FrieslandCampina (Friso) Business Overview
  28. 7.5.3 FrieslandCampina (Friso) HMO Infant Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 FrieslandCampina (Friso) HMO Infant Formula Product Portfolio
  30. 7.5.5 FrieslandCampina (Friso) Recent Developments
  31. 7.6 Biostime
  32. 7.6.1 Biostime Company Information
  33. 7.6.2 Biostime Business Overview
  34. 7.6.3 Biostime HMO Infant Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Biostime HMO Infant Formula Product Portfolio
  36. 7.6.5 Biostime Recent Developments
  37. 7.7 Yili Group (Ausnutria Dairy)
  38. 7.7.1 Yili Group (Ausnutria Dairy) Company Information
  39. 7.7.2 Yili Group (Ausnutria Dairy) Business Overview
  40. 7.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Yili Group (Ausnutria Dairy) HMO Infant Formula Product Portfolio
  42. 7.7.5 Yili Group (Ausnutria Dairy) Recent Developments
8 North America
  1. 8.1 North America HMO Infant Formula Market Size by Type
  2. 8.1.1 North America HMO Infant Formula Revenue by Type (2021-2032)
  3. 8.1.2 North America HMO Infant Formula Sales by Type (2021-2032)
  4. 8.1.3 North America HMO Infant Formula Price by Type (2021-2032)
  5. 8.2 North America HMO Infant Formula Market Size by Application
  6. 8.2.1 North America HMO Infant Formula Revenue by Application (2021-2032)
  7. 8.2.2 North America HMO Infant Formula Sales by Application (2021-2032)
  8. 8.2.3 North America HMO Infant Formula Price by Application (2021-2032)
  9. 8.3 North America HMO Infant Formula Market Size by Country
  10. 8.3.1 North America HMO Infant Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America HMO Infant Formula Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America HMO Infant Formula Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe HMO Infant Formula Market Size by Type
  2. 9.1.1 Europe HMO Infant Formula Revenue by Type (2021-2032)
  3. 9.1.2 Europe HMO Infant Formula Sales by Type (2021-2032)
  4. 9.1.3 Europe HMO Infant Formula Price by Type (2021-2032)
  5. 9.2 Europe HMO Infant Formula Market Size by Application
  6. 9.2.1 Europe HMO Infant Formula Revenue by Application (2021-2032)
  7. 9.2.2 Europe HMO Infant Formula Sales by Application (2021-2032)
  8. 9.2.3 Europe HMO Infant Formula Price by Application (2021-2032)
  9. 9.3 Europe HMO Infant Formula Market Size by Country
  10. 9.3.1 Europe HMO Infant Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe HMO Infant Formula Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe HMO Infant Formula Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China HMO Infant Formula Market Size by Type
  2. 10.1.1 China HMO Infant Formula Revenue by Type (2021-2032)
  3. 10.1.2 China HMO Infant Formula Sales by Type (2021-2032)
  4. 10.1.3 China HMO Infant Formula Price by Type (2021-2032)
  5. 10.2 China HMO Infant Formula Market Size by Application
  6. 10.2.1 China HMO Infant Formula Revenue by Application (2021-2032)
  7. 10.2.2 China HMO Infant Formula Sales by Application (2021-2032)
  8. 10.2.3 China HMO Infant Formula Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia HMO Infant Formula Market Size by Type
  2. 11.1.1 Asia HMO Infant Formula Revenue by Type (2021-2032)
  3. 11.1.2 Asia HMO Infant Formula Sales by Type (2021-2032)
  4. 11.1.3 Asia HMO Infant Formula Price by Type (2021-2032)
  5. 11.2 Asia HMO Infant Formula Market Size by Application
  6. 11.2.1 Asia HMO Infant Formula Revenue by Application (2021-2032)
  7. 11.2.2 Asia HMO Infant Formula Sales by Application (2021-2032)
  8. 11.2.3 Asia HMO Infant Formula Price by Application (2021-2032)
  9. 11.3 Asia HMO Infant Formula Market Size by Country
  10. 11.3.1 Asia HMO Infant Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia HMO Infant Formula Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia HMO Infant Formula Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA HMO Infant Formula Market Size by Type
  2. 12.1.1 SAMEA HMO Infant Formula Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA HMO Infant Formula Sales by Type (2021-2032)
  4. 12.1.3 SAMEA HMO Infant Formula Price by Type (2021-2032)
  5. 12.2 SAMEA HMO Infant Formula Market Size by Application
  6. 12.2.1 SAMEA HMO Infant Formula Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA HMO Infant Formula Sales by Application (2021-2032)
  8. 12.2.3 SAMEA HMO Infant Formula Price by Application (2021-2032)
  9. 12.3 SAMEA HMO Infant Formula Market Size by Country
  10. 12.3.1 SAMEA HMO Infant Formula Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA HMO Infant Formula Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA HMO Infant Formula Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 HMO Infant Formula Value Chain Analysis
  2. 13.1.1 HMO Infant Formula Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 HMO Infant Formula Production Mode & Process
  6. 13.2 HMO Infant Formula Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 HMO Infant Formula Distributors
  9. 13.2.3 HMO Infant Formula Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst